Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-26

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Pramipexole dihydrochloride from ScieGen Pharmaceuticals Inc, confirming approval of a generic product. The drug is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)